Long-circulating liposomes co-encapsulating doxorubicin and curcumin for increased efficiency of colon cancer therapy
- In: Poster Presentation
- At: Stockholm (Sweden) (2017)
- Type: Poster
- Poster code: P-B-113-Tuesday
- By: TEFAS, Lucia ("Iuliu Hatieganu" University of Medicine and Pharmacy, Pharmaceutical Technology and Biopharmaceutics, Cluj-Napoca, Romania)
- Co-author(s): Lucia Tefas: Pharmaceutical Technology and Biopharmaceutics, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania
Alina Sesarman: Department of Molecular Biology and Biotechnology, Babes-Bolyai University, Cluj-Napoca, Romania
Bianca Sylvester: Pharmaceutical Technology and Biopharmaceutics, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania
Emilia Licarete: Department of Molecular Biology and Biotechnology, Babes-Bolyai University, Cluj-Napoca, Romania
Valentin Rauca: Department of Molecular Biology and Biotechnology, Babes-Bolyai University, Cluj-Napoca, Romania
Lavinia Luput: Department of Molecular Biology and Biotechnology, Babes-Bolyai University, Cluj-Napoca, Romania
Laura Patras: Department of Molecular Biology and Biotechnology, Babes-Bolyai University, Cluj-Napoca, Romania
Manuela Banciu: Department of Molecular Biology and Biotechnology, Babes-Bolyai University, Cluj-Napoca, Romania
Alina Porfire: Pharmaceutical Technology and Biopharmaceutics, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania - Abstract:
Backgrounds
The current strategies in colon cancer therapy are aiming to enhance the efficiency through combination treatments and increase the accumulation of anticancer agents in tumor cells by using drug delivery systems.Aims
This study aimed at developing doxorubicin (DOX) and curcumin (CUR) co-loaded PEGylated liposomes (DOX-CUR-LCL) and.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023